Literature DB >> 2357105

A catabolic state in dexamethasone treatment of bronchopulmonary dysplasia.

P D Macdonald, P Galea, L G Alroomi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357105      PMCID: PMC1792161          DOI: 10.1136/adc.65.5.560-c

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  2 in total

1.  Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia.

Authors:  G B Avery; A B Fletcher; M Kaplan; D S Brudno
Journal:  Pediatrics       Date:  1985-01       Impact factor: 7.124

2.  Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.

Authors:  M C Mammel; T P Green; D E Johnson; T R Thompson
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

  2 in total
  2 in total

1.  Pharmacokinetics of dexamethasone in premature neonates.

Authors:  R A Lugo; M C Nahata; J A Menke; R E McClead
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.

Authors:  A F Williams; M Jones
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.